Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 7, 2017

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Non Small Cell Lung CancerSecondary Lung Cancer
Interventions
BEHAVIORAL

Personalized Exercise Program

"The PEP intervention involves a combination of home-based exercise as well as in-patient exercise. The exercise modes will include basic transfer and calisthenics mobility, aerobic and resistance exercises and will be performed in various postures (supine, sitting, standing and walking) with variable challenges (level walking, bending, inclines, steps and squatting).~For patients randomized to the Intervention Group (Group 1), the PEP intervention will be personalized, implemented, and modified (based on the patients AM-PAC mobility stage) by a licensed physical therapist in face-to-face, virtual, or phone meetings (\~30-40 minutes). An exercise education manual, specifically developed for this study, will be used by the physical therapist to educate the patients on all aspects of starting and maintaining the exercise intervention."

Trial Locations (1)

84112

Huntsman Cancer Institute, Salt Lake City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

University of Utah

OTHER

NCT03306992 - Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study | Biotech Hunter | Biotech Hunter